• The Gastric bypass stent system obtained medical device registration certificates in countries and regions including Hong Kong, Thailand, Vietnam, Saudi Arabia, Malaysia and Ecuador.

• Our Gastric bypass stent system was recommended in the Expert consensus on weight management clinic setting (2025 edition) and Expert opinion on endoscopic duodenal-jejunal bypass liner implantation for weight loss (2025 edition).

• We obtained “International Medical Innovation Competition - Medical Innovation Award” by CIIE Exhibition Union Medical Devices Committee.

• We completed first implantation of our DIGB for pivotal clinical trial in China.

• Our Gastric bypass stent system received approval from the NMPA in January and became the first medical device approved for digestive endoscopic treatment of obesity in China.

• We commercialized our Gastric bypass stent system launched by the NHC against the backdrop of the three-year “Weight Management Year” campaign (2024–2026).

• Our Gastric bypass stent system-SH has been granted Breakthrough Device Designation by the FDA.

• Our Gastric Bypass Stent System was recommended in the Guideline for Diagnosis and Treatment of Obesity (2024 edition) issued by the NHC and the Expert Consensus on Digestive Endoscopic Treatment of Obesity in China.

• We obtained medical device registration certificate in Indonesia for the Gastric bypass stent system.

• We completed the NMPA submission of the Gastric bypass stent system for review.

• We completed the clinical trial for the Gastric bypass stent system and met the primary endpoints of the clinical study of Gastric bypass stent system in China.

• We obtained “2022 National Disruptive Innovation Competition Excellence Award” by Torch Center of Ministry of Science and Technology.

• Our product/solution was honored with the “2021 Best Smart Healthcare Solution Product” award by the Global New Economy Outstanding Achievement Awards Committee.

• The Gastric bypass stent system was admitted into the Green Path for Innovative Medical Device by NMPA.

• We commenced the research and development of our Core Product, the Gastric bypass stent system, in Hangzhou.

• Our Company was established.